Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir is a research paper published in Journal of Antimicrobial Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Centers of Excellence for Influenza Research and Surveillance
Grant: HHSN272201400006C
Avisa Pharmaceuticals LLC
Chemical Diversity Research Institute
NIAID
NIH
FWCI
0.88
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals